ArticleAddiction (Abingdon, England)2023
Associations of recreational cannabis dispensaries' availability, storefront signage and health benefit signs with cannabis use: findings from a representative adult sample in California, United States.
Article in Addiction (Abingdon, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 34 citations in OpenAlex.
- Cannabis dispensary exposure and smoked, vaped and edible cannabis use among young adults: Comparison of web-scraped and government-maintained registries.Addiction (Abingdon, England) · 2026Article
- Emergency department use by individuals with and without psychosis after state-level cannabis legalization and commercialization.Nature. Mental health · 2026Article
- Effects of textual warnings and warning symbols on cannabis advertisements on product perceptions among US young adults.Health education research · 2026Article
- Cannabis Use Among Individuals With Psychosis After State-Level Commercial Cannabis Legalization.JAMA psychiatry · 2026Article
- Centering Individuals With Mental Illness as an At-Risk Group in the Era of Cannabis Legalization and Commercialization.Clinical therapeutics · 2026Article
- Prevalence and reasons for using cannabidiol, delta-8 tetrahydrocannabinol, cannabinol, cannabigerol, and hexahydrocannabinol among US adults.Journal of cannabis research · 2025Article
- Development and evaluation of a method to compile a national list of cannabis dispensaries.Drug and alcohol dependence · 2025Article
- U.S. State Marijuana and Delta-8-Tetrahydrocannabinol Laws and Delta-8-Tetrahydrocannabinol Use.American journal of preventive medicine · 2025Article
- Young Adults' Experiences with Cannabis Retailer Marketing and Related Practices: Differences Among Sociodemographic Groups and Associations with Cannabis Use-related Outcomes.Journal of racial and ethnic health disparities · 2025Article
- The Unequal Geography of Recreational Cannabis Retailers in the U.S.American journal of preventive medicine · 2025Article
- Prevalence of cannabis and medication use by indices of residential urbanicity and deprivation among Ohio cancer patients.Cancer causes & control : CCC · 2025Article
- Cannabis Marketing Strategies in the United States: A Descriptive Analysis of Four Prominent Companies.Substance use & addiction journal · 2025Article
- Use of Tobacco and Cannabis Following State-Level Cannabis Legalization.JAMA network open · 2025Article
- Association of Recreational Cannabis Legalization with Frequency of Using Cannabis for Sleep.Journal of psychoactive drugs · 2025Article
- Commentary on Pessar et al.: 'Downscaling' United States state cannabis policy to investigate environmental and social impacts on cannabis use.Addiction (Abingdon, England) · 2025Article
- Budtender Perceptions and Knowledge of Cannabis and Mental Health: A Preliminary Study.Cannabis (Albuquerque, N.M.) · 2025Article
- A Narrative Review of Research on Cannabis Advertising in the United States.Current addiction reports · 2025Review
- Historical change in associations between perceived risk, disapproval, and use of cannabis among young adults ages 19-30, 2011-2022.Addictive behaviors · 2025Article
- The association between state cannabis policies and cannabis use among adults and youth, United States, 2002-2019.Addiction (Abingdon, England) · 2025Article
- Neighborhood demographics in relation to marketing and regulation-related factors among cannabis retailers in 5 US cities.Drug and alcohol dependence · 2024Article
Corrections and comments
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
BACKGROUND AND
aimsThere are concerns that availability of recreational cannabis dispensaries (RCDs) and point-of-sale marketing may lead to increased cannabis use in jurisdictions where cannabis retail sale is legal. This paper examined whether the availability RCDs and the presence of storefront signage indicative of cannabis and signs promoting health benefits in RCDs were associated with cannabis use and risk perceptions.
designCross-sectional, secondary data analysis.
settingCalifornia, USA.
participantsA representative sample of 3385 adults in California who participated in the 2020 probability-based Marijuana Use and Environment Survey. MEASUREMENTS: Binary outcomes included past-month overall cannabis use, perceiving cannabis smoking as harmful and past-month cannabis use by purpose (medical only, recreational only and dual). The objectively assessed predictors included proximity and density of RCDs and presence of storefront signage indicative of cannabis and signs promoting health benefits in RCDs.
findingsIn terms of proximity, thepresence of storefront signage in the nearest RCD was associated with smaller odds of perceiving cannabis smoking as harmful [odds ratio (OR) = 0.63, 95% confidence interval (CI) = 0.39, 0.99] if the RCD was located within 2 miles of home. Presence of health benefit signs in the nearest RCD was associated with greater odds of overall cannabis use (OR = 2.45, 95% CI = 1.17, 5.16) and recreational use (OR = 3.50, 95% CI = 1.027, 11.91) if the RCD was located within 2-4 miles of home. In terms of density, count of RCDs, count of RCDs with storefront signage and count of RCDs with health benefit signs within 2 miles of home were each separately associated with greater odds of overall cannabis use and cannabis use for dual purposes.
conclusionsThe availability of recreational cannabis dispensaries within 2 miles of one's home and the presence of storefront signage indicating the availability of cannabis and signs promoting health benefits of cannabis appear to be associated with increased cannabis use and reduced risk perceptions among adults in California, USA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.